{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:21:50Z","timestamp":1777576910900,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.vaccine.2012.11.065","type":"journal-article","created":{"date-parts":[[2012,12,7]],"date-time":"2012-12-07T09:01:39Z","timestamp":1354870899000},"page":"1420-1425","source":"Crossref","is-referenced-by-count":36,"title":["Leishmanization revisited: Immunization with a naturally attenuated cutaneous Leishmania donovani isolate from Sri Lanka protects against visceral leishmaniasis"],"prefix":"10.1016","volume":"31","author":[{"given":"Laura-Isobel","family":"McCall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanlindra","family":"Ranasinghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg","family":"Matlashewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9496","key":"10.1016\/j.vaccine.2012.11.065_bib0005","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances in leishmaniasis","volume":"366","author":"Murray","year":"2005","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.vaccine.2012.11.065_bib0010","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.vaccine.2012.11.065_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000114","article-title":"Measuring the burden of neglected tropical diseases: the global burden of disease framework","volume":"1","author":"Mathers","year":"2007","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2012.11.065_bib0020","article-title":"Vaccines for the Leishmaniases: proposals for a research agenda","volume":"5","author":"Costa","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"52","key":"10.1016\/j.vaccine.2012.11.065_bib0025","doi-asserted-by":"crossref","first-page":"6759","DOI":"10.1016\/j.vaccine.2008.09.085","article-title":"First generation leishmaniasis vaccines: a review of field efficacy trials","volume":"26","author":"Noazin","year":"2008","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2012.11.065_bib0030","doi-asserted-by":"crossref","first-page":"826","DOI":"10.4269\/ajtmh.1994.51.826","article-title":"Endemic Kala-Azar in Eastern Sudan \u2013 a longitudinal-study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis","volume":"51","author":"Zijlstra","year":"1994","journal-title":"Am J Trop Med Hyg"},{"issue":"Pt 5","key":"10.1016\/j.vaccine.2012.11.065_bib0035","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/icb.1987.44","article-title":"Heterologous protection in murine cutaneous leishmaniasis","volume":"65","author":"Mitchell","year":"1987","journal-title":"Immunol Cell Biol"},{"issue":"7","key":"10.1016\/j.vaccine.2012.11.065_bib0040","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.vaccine.2011.12.067","article-title":"Comparative assessment of a DNA and protein Leishmania donovani gamma glutamyl cysteine synthetase vaccine to cross-protect against murine cutaneous leishmaniasis caused by L. major or L. mexicana infection","volume":"30","author":"Campbell","year":"2012","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2012.11.065_bib0045","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.vaccine.2008.12.053","article-title":"KMP-11 DNA immunization significantly protects against L. donovani infection but requires exogenous IL-12 as an adjuvant for comparable protection against L. major","volume":"27","author":"Bhaumik","year":"2009","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2012.11.065_bib0050","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.4049\/jimmunol.0900276","article-title":"Intracellular replication-deficient Leishmania donovani induces long lasting protective immunity against visceral leishmaniasis","volume":"183","author":"Selvapandiyan","year":"2009","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2012.11.065_bib0055","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4269\/ajtmh.2007.76.579","article-title":"Cross-protection against Leishmania donovani but not L. braziliensis caused by vaccination with L. major soluble promastigote exogenous antigens in BALB\/c mice","volume":"76","author":"Tonui","year":"2007","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.vaccine.2012.11.065_bib0060","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.4049\/jimmunol.166.3.1921","article-title":"Protective immunity against the protozoan Leishmania chagasi is induced by subclinical cutaneous infection with virulent but not avirulent organisms","volume":"166","author":"Streit","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2012.11.065_bib0065","doi-asserted-by":"crossref","DOI":"10.1007\/s00436-012-2899-5","article-title":"Previous exposure to a low infectious dose of Leishmania major exacerbates infection with Leishmania infantum in the susceptible BALB\/c mouse","author":"Nation","year":"2012","journal-title":"Parasitol Res"},{"issue":"10","key":"10.1016\/j.vaccine.2012.11.065_bib0070","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.pt.2009.07.002","article-title":"Leishmania donovani causing cutaneous leishmaniasis in Sri Lanka: a wolf in sheep's clothing?","volume":"25","author":"Karunaweera","year":"2009","journal-title":"Trends Parasitol"},{"issue":"5","key":"10.1016\/j.vaccine.2012.11.065_bib0075","first-page":"632","article-title":"Candidate gene study of susceptibility to cutaneous leishmaniasis in Sri Lanka","volume":"15","author":"Samaranayake","year":"2010","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.vaccine.2012.11.065_bib0080","first-page":"E386","article-title":"Inherited susceptibility to cutaneous leishmaniasis in Sri Lanka","volume":"12","author":"Samaranayake","year":"2008","journal-title":"Int J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2012.11.065_bib0215","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1179\/2047773212Y.0000000054","article-title":"Leishmania donovani zymodeme MON-37 isolated from an autochthonous visceral leishmaniasis patient in Sri Lanka","volume":"106","author":"Ranasinghe","year":"2012","journal-title":"Path Glob Health"},{"issue":"3","key":"10.1016\/j.vaccine.2012.11.065_bib0090","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3201\/eid1303.060242","article-title":"Leishmania donovani and cutaneous leishmaniasis, Sri Lanka","volume":"13","author":"Siriwardana","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2012.11.065_bib0095","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0035-9203(03)90061-7","article-title":"Lankan cutaneous leishmaniasis is caused by Leishmania donovani zymodeme MON-37","volume":"97","author":"Karunaweera","year":"2003","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"16","key":"10.1016\/j.vaccine.2012.11.065_bib0100","doi-asserted-by":"crossref","first-page":"8807","DOI":"10.1073\/pnas.94.16.8807","article-title":"Loss of virulence in Leishmania donovani deficient in an amastigote-specific protein, A2","volume":"94","author":"Zhang","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1\/2","key":"10.1016\/j.vaccine.2012.11.065_bib0105","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0264-410X(01)00322-X","article-title":"Immunization with A2 protein results in a mixed Th1\/Th2 and a humoral response which protects mice against Leishmania donovani infections","volume":"20","author":"Ghosh","year":"2001","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2012.11.065_bib0110","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2149\/tmh.2008-21","article-title":"Morphological and molecular studies on Sri Lankan leishmania","volume":"36","author":"Yatawara","year":"2008","journal-title":"Trop Med Health"},{"issue":"5","key":"10.1016\/j.vaccine.2012.11.065_bib0115","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.vaccine.2005.08.057","article-title":"Imprinting of BALB\/c mice with low Leishmania infantum parasite dose markedly protects spleen against high-dose challenge","volume":"24","author":"Ferrua","year":"2006","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2012.11.065_bib0120","first-page":"340","article-title":"Sustained parasite burden in the spleen of Leishmania infantum-infected BALB\/c mice is accompanied by expression of MCP-1 transcripts and lack of protection against challenge","volume":"12","author":"Rousseau","year":"2001","journal-title":"Eur Cytokine Netw"},{"issue":"5","key":"10.1016\/j.vaccine.2012.11.065_bib0125","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.4049\/jimmunol.179.5.3161","article-title":"SIR2-deficient Leishmania infantam induces a defined IFN-gamma\/IL-10 pattern that correlates with protection","volume":"179","author":"Silvestre","year":"2007","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2012.11.065_bib0130","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1128\/CVI.05660-11","article-title":"Killed but metabolically active Leishmania infantum as a novel whole-cell vaccine for visceral leishmaniasis","volume":"19","author":"Bruhn","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2012.11.065_bib0135","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/sj.icb7100011","article-title":"Balancing immunity and pathology in visceral leishmaniasis","volume":"85","author":"Stanley","year":"2007","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2012.11.065_bib0140","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1471-2334-5-113","article-title":"Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis","volume":"5","author":"Caldas","year":"2005","journal-title":"BMC Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2012.11.065_bib0145","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1002\/eji.200939455","article-title":"Murine visceral leishmaniasis: IgM and polyclonal B-cell activation lead to disease exacerbation","volume":"40","author":"Deak","year":"2010","journal-title":"Eur J Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2012.11.065_bib0150","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.it.2007.07.004","article-title":"Interleukin-10 and the pathogenesis of human visceral leishmaniasis","volume":"28","author":"Nylen","year":"2007","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2012.11.065_bib0155","doi-asserted-by":"crossref","first-page":"892817","DOI":"10.1155\/2012\/892817","article-title":"Development of vaccines against visceral leishmaniasis","volume":"2012","author":"Evans","year":"2012","journal-title":"J Trop Med"},{"issue":"6","key":"10.1016\/j.vaccine.2012.11.065_bib0160","first-page":"412","article-title":"Immunobiology of leishmaniasis","volume":"47","author":"Sharma","year":"2009","journal-title":"Indian J Exp Biol"},{"issue":"10","key":"10.1016\/j.vaccine.2012.11.065_bib0165","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/ni1249","article-title":"Activation of bone marrow-resident memory T cells by circulating, antigen-bearing dendritic cells","volume":"6","author":"Cavanagh","year":"2005","journal-title":"Nat Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2012.11.065_bib0170","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.coi.2006.05.011","article-title":"Generation, migration and function of circulating dendritic cells","volume":"18","author":"Bonasio","year":"2006","journal-title":"Curr Opin Immunol"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2012.11.065_bib0175","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nri1869","article-title":"Tissue-tropic effector T cells: generation and targeting opportunities","volume":"6","author":"Agace","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"January (5\/6)","key":"10.1016\/j.vaccine.2012.11.065_bib0180","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0264-410X(02)00407-3","article-title":"Memory T cells and vaccines","volume":"21","author":"Esser","year":"2003","journal-title":"Vaccine"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2012.11.065_bib0185","doi-asserted-by":"crossref","first-page":"6372","DOI":"10.1128\/IAI.73.10.6372-6382.2005","article-title":"Live nonpathogenic parasitic vector as a candidate vaccine against visceral leishmaniasis","volume":"73","author":"Breton","year":"2005","journal-title":"Infect Immun"},{"issue":"December (6915)","key":"10.1016\/j.vaccine.2012.11.065_bib0190","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nature01152","article-title":"CD4(+)CD25(+) regulatory T cells control Leishmania major persistence and immunity","volume":"420","author":"Belkaid","year":"2002","journal-title":"Nature"},{"issue":"Decmber (12)","key":"10.1016\/j.vaccine.2012.11.065_bib0195","doi-asserted-by":"crossref","first-page":"6967","DOI":"10.4049\/jimmunol.167.12.6967","article-title":"Immune elimination of Leishmania major in mice: implications for immune memory, vaccination, and reactivation disease","volume":"167","author":"Uzonna","year":"2001","journal-title":"J Immunol"},{"issue":"November (9241)","key":"10.1016\/j.vaccine.2012.11.065_bib0200","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(00)03128-7","article-title":"Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan","volume":"356","author":"Khalil","year":"2000","journal-title":"Lancet"},{"issue":"May (22)","key":"10.1016\/j.vaccine.2012.11.065_bib0205","doi-asserted-by":"crossref","first-page":"9375","DOI":"10.1073\/pnas.0703678104","article-title":"Evolutionary and geographical history of the Leishmania donovani complex with a revision of current taxonomy","volume":"104","author":"Lukes","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2012.11.065_bib0210","doi-asserted-by":"crossref","first-page":"631460","DOI":"10.1155\/2012\/631460","article-title":"Immunity to visceral leishmaniasis using genetically defined live-attenuated parasites","volume":"2012","author":"Selvapandiyan","year":"2012","journal-title":"J Trop Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1201715X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1201715X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T20:12:29Z","timestamp":1562443949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1201715X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0264410X1201715X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.11.065","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}